Avoro Capital Advisors’s Iovance Biotherapeutics IOVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-3,500,000
Closed -$25.9M 36
2024
Q4
$25.9M Sell
3,500,000
-740,000
-17% -$5.48M 0.37% 32
2024
Q3
$39.8M Sell
4,240,000
-7,460,000
-64% -$70M 0.58% 28
2024
Q2
$93.8M Hold
11,700,000
1.25% 20
2024
Q1
$173M Buy
11,700,000
+5,000,000
+75% +$74.1M 2.02% 17
2023
Q4
$54.5M Hold
6,700,000
0.75% 22
2023
Q3
$30.5M Hold
6,700,000
0.48% 25
2023
Q2
$47.2M Sell
6,700,000
-320,000
-5% -$2.25M 0.64% 24
2023
Q1
$42.9M Hold
7,020,000
0.64% 22
2022
Q4
$44.9M Sell
7,020,000
-2,000,000
-22% -$12.8M 0.67% 24
2022
Q3
$86.4M Sell
9,020,000
-200,000
-2% -$1.92M 1.6% 17
2022
Q2
$102M Buy
9,220,000
+95,000
+1% +$1.05M 2.01% 14
2022
Q1
$152M Buy
9,125,000
+450,000
+5% +$7.49M 2.77% 14
2021
Q4
$166M Buy
8,675,000
+175,000
+2% +$3.34M 2.82% 11
2021
Q3
$210M Sell
8,500,000
-600,000
-7% -$14.8M 3.29% 8
2021
Q2
$237M Buy
9,100,000
+1,100,000
+14% +$28.6M 4.12% 8
2021
Q1
$253M Buy
8,000,000
+500,000
+7% +$15.8M 4.37% 8
2020
Q4
$348M Sell
7,500,000
-2,036,039
-21% -$94.5M 5.99% 4
2020
Q3
$314M Sell
9,536,039
-825,000
-8% -$27.2M 4.46% 4
2020
Q2
$284M Buy
10,361,039
+1,350,626
+15% +$37.1M 5.62% 4
2020
Q1
$270M Buy
9,010,413
+184,374
+2% +$5.52M 9.1% 3
2019
Q4
$244M Sell
8,826,039
-1,775,000
-17% -$49.1M 7.17% 4
2019
Q3
$193M Sell
10,601,039
-151,546
-1% -$2.76M 8.05% 3
2019
Q2
$264M Buy
10,752,585
+221,723
+2% +$5.44M 9.11% 3
2019
Q1
$100M Buy
10,530,862
+269,823
+3% +$2.57M 4.33% 10
2018
Q4
$90.8M Buy
10,261,039
+1,598,319
+18% +$14.1M 5.43% 7
2018
Q3
$97.5M Buy
8,662,720
+485,000
+6% +$5.46M 4.48% 8
2018
Q2
$105M Buy
8,177,720
+99,215
+1% +$1.27M 4.03% 8
2018
Q1
$137M Buy
8,078,505
+2,825,055
+54% +$47.7M 6.52% 4
2017
Q4
$42M Buy
5,253,450
+1,052,107
+25% +$8.42M 2.72% 15
2017
Q3
$32.6M Buy
4,201,343
+50,000
+1% +$387K 2.53% 16
2017
Q2
$30.5M Sell
4,151,343
-400,000
-9% -$2.94M 3.85% 10
2017
Q1
$33.9M Buy
4,551,343
+30,700
+0.7% +$229K 4.33% 8
2016
Q4
$31.4M Buy
4,520,643
+263,296
+6% +$1.83M 6.35% 4
2016
Q3
$35M Sell
4,257,347
-81,210
-2% -$668K 6.15% 3
2016
Q2
$35.1M Buy
4,338,557
+1,213,359
+39% +$9.83M 7.81% 2
2016
Q1
$15.9M Sell
3,125,198
-62,409
-2% -$317K 5.54% 7
2015
Q4
$24.6M Buy
3,187,607
+6,694
+0.2% +$51.7K 8.48% 3
2015
Q3
$18.3M Buy
3,180,913
+257,848
+9% +$1.49M 4.76% 8
2015
Q2
$26.8M Buy
2,923,065
+773,158
+36% +$7.09M 7.38% 4
2015
Q1
$26M Buy
+2,149,907
New +$26M 9.99% 2